QQ客服 官方微博 反馈留言

	A Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined with Yangzheng Xiaoji in Advanced NSCLC
	Xing, L.; Wang, J.; Li, L.; Ma, Z.; Hu, C.; Zhang, H.; Shan, L.; Chen, Z.; Zhang, J.; Zhou, Q.
刊名	JOURNAL OF THORACIC ONCOLOGY
	2018
卷号	13页码:S359-S360
关键词	chemotherapy Yangzheng Xiaoji (YZXJ) Advanced Non-Small Cell Lung Cancer
ISSN号	1556-0864
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2912868
专题	西安交通大学
推荐引用方式 GB/T 7714	Xing, L.,Wang, J.,Li, L.,et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined with Yangzheng Xiaoji in Advanced NSCLC[J]. JOURNAL OF THORACIC ONCOLOGY,2018,13:S359-S360.
APA	Xing, L..,Wang, J..,Li, L..,Ma, Z..,Hu, C..,...&Yu, J..(2018).A Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined with Yangzheng Xiaoji in Advanced NSCLC.JOURNAL OF THORACIC ONCOLOGY,13,S359-S360.
MLA	Xing, L.,et al."A Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined with Yangzheng Xiaoji in Advanced NSCLC".JOURNAL OF THORACIC ONCOLOGY 13(2018):S359-S360.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。